Disease Rebound After Stopping Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis

    loading  Checking for direct PDF access through Ovid

Abstract

A review of patients with relapsing-remitting multiple sclerosis who discontinued fingolimod therapy showed that five out of 46 (10.9 %) of these patients developed a rebound phenomenon between 4 to 16 weeks, where disease activity returns and often exceeds pre-treatment levels.

Related Topics

    loading  Loading Related Articles